InvestorQ : Can you tell me about the latest drug approval received by Lupin from the USFDA?
NISHA Nayak made post

Can you tell me about the latest drug approval received by Lupin from the USFDA?

Answer
image
Priyanka N answered.
3 weeks ago
Follow

Lupin announced that it had secured approval from the US Food and Drug Administration or FDA to market Droxidopa capsules which is popularly used to treat dizziness. The USFDA has come for Droxidopa capsules having strength of 100 mg, 200 mg, and 300 mg. This is a generic version of Lundbeck's Northera capsules, which is also meant to treat dizziness. Lupin proposes to manufacture the drug at its Nagpur facility.

Droxidopa Capsules are used to treat orthostatic dizziness and light-headedness in patients. Droxidopa capsules had estimated annual sales of $352 million in the US
0 Views